Emcure revenue up 24.3% as profit growth outpaces sales
Emcure's Q2FY27 revenue rose 24.3% year on year, EBITDA grew 30.9% and PAT 29.3%; international sales up 34.5%, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Emcure's revenue for the second quarter of fiscal 2027 rose 24.3% year on year, according to TradingView. EBITDA increased 30.9%, while profit after tax (PAT) grew 29.3%.
International revenue climbed 34.5%. The domestic business expects growth to continue through the full fiscal year as its portfolio gains traction.
why it matters
Profit growing faster than revenue points to improving profitability at the business. The report covers a single company, so its impact on the broader market is limited.
market impact
Emcure shares: profit growth ahead of sales growth supports the stock
- Emcure shares pressure up — EBITDA and profit growth faster than revenue lifts margins
tags
instruments
sources
- EMCURE: Revenue rose 24.3% as EBITDA and PAT growth outpaced sales — TradingView, 3 November 2026 at 09:43 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗